Bert van Meurs
Fortuna: 124 573 $ al 31/07/2026
Fortuna: 124 573 $ al 31/07/2026
Bert van Meurs currently works at Koninklijke Philips NV, as EVP & Chief Business Leader-Diagnostics, QIAGEN NV, as Member-Supervisory Board from 2024, and Image Guided Therapy, as Executive Vice President.
Mr. van Meurs received his undergraduate degree from Technische Universiteit Eindhoven and graduate degree from the University of Utrecht.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
QIAGEN NV 0 % | 28/02/2026 | 3.009 ( 0 % ) | 124 573 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| PHILIPS NV | Corporate Officer/Principal | 01/01/2019 |
| QIAGEN N.V. | Director/Miembro de la Junta | 01/04/2024 |
Image Guided Therapy
Image Guided Therapy Medical SpecialtiesHealth Technology Develops medical devices to the treatment of cancer | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Koninklijke Philips NV
Koninklijke Philips NV Medical/Nursing ServicesHealth Services Provides image, cardiovascular, diagnostic imaging, ambulatory, sleep therapy and personal healthcare services | Health Services |
QIAGEN NV
QIAGEN NV Medical SpecialtiesHealth Technology Manufactures and distributes sample and assay technology products for pre-analytical sample preparations | Health Technology |
Technische Universiteit Eindhoven
Technische Universiteit Eindhoven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Utrecht
University of Utrecht Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Image Guided Therapy
Image Guided Therapy Medical SpecialtiesHealth Technology Develops medical devices to the treatment of cancer | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.